InvestSMART

Syntara Limited (ASX: SNT) - Announcements

Current share price for SNT : $0.022 0.002 (8.33%)+

ASX company news and announcements for Syntara Limited (SNT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Syntara Limited (SNT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Syntara Limited (SNT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Syntara Limited (SNT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$43 Proposed issue of securities to the CEO 2 Jul 2025 11:20AM $0.051 $0.022 fallen by 56.86%
$43 Notification regarding unquoted securities - SNT 2 Jul 2025 11:16AM $0.051 $0.022 fallen by 56.86%
$43 Application for quotation of securities - SNT 1 Jul 2025 12:55PM $0.051 $0.022 fallen by 56.86%
$43 Ceasing to be a substantial holder 23 Jun 2025 8:25AM $0.049 $0.022 fallen by 55.10%
$43 Application for quotation of securities - SNT 16 Jun 2025 12:19PM $0.058 $0.022 fallen by 62.07%
$43 EHA 2025 SNT-5505 Interim Data Webinar Presentation 13 Jun 2025 10:42AM $0.074 $0.022 fallen by 70.27%
$43 New positive interim data in Phase 2 study of SNT-5505 13 Jun 2025 8:36AM $0.068 $0.022 fallen by 67.65%
$43 SNT-5505 interim Phase 2 data webinar 13 Jun 2025 8:26AM $0.068 $0.022 fallen by 67.65%
$43 Application for quotation of securities - SNT 10 Jun 2025 4:25PM $0.069 $0.022 fallen by 68.12%
$43 SNT-5505 awarded US FDA Fast Track designation 10 Jun 2025 9:03AM $0.069 $0.022 fallen by 68.12%
$43 Change in substantial holding 26 May 2025 8:37AM $0.067 $0.022 fallen by 67.16%
$43 Change in substantial holding 22 May 2025 3:44PM $0.066 $0.022 fallen by 66.67%
$43 Investor Presentation 7 May 2025 11:41AM $0.065 $0.022 fallen by 66.15%
$43 March Quarter Shareholder Update Presentation 1 May 2025 11:12AM $0.055 $0.022 fallen by 60%
$43 Appendix 4C quarterly webinar 30 Apr 2025 9:39AM $0.053 $0.022 fallen by 58.49%
$43 Quarterly Activities Report 30 Apr 2025 9:03AM $0.053 $0.022 fallen by 58.49%
$43 Quarterly Appendix 4C Cash Flow Report 30 Apr 2025 8:55AM $0.053 $0.022 fallen by 58.49%
$43 Updated SNT-5505 study data to be presented at EHA2025 29 Apr 2025 9:18AM $0.049 $0.022 fallen by 55.10%
$43 Change in substantial holding 24 Apr 2025 3:58PM $0.054 $0.022 fallen by 59.26%
$43 Change in substantial holding 31 Mar 2025 4:57PM $0.076 $0.022 fallen by 71.05%
$43 Notification of cessation of securities - SNT 28 Mar 2025 4:41PM $0.076 $0.022 fallen by 71.05%
$43 Application for quotation of securities - SNT 28 Mar 2025 4:41PM $0.076 $0.022 fallen by 71.05%
$43 Change in substantial holding 24 Mar 2025 2:46PM $0.081 $0.022 fallen by 72.84%
$43 Skin scarring webinar featuring Professor Fiona Wood 18 Mar 2025 8:22AM $0.079 $0.022 fallen by 72.15%
$43 Acceleration of skin scarring program 18 Mar 2025 8:19AM $0.079 $0.022 fallen by 72.15%

101 - 125 of 268 results

Page 5 of 11

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.